Neal Singh, COO of software company Icertis discusses how technology, in particular AI is helping to fast track drug discovery within research and development (R&D).
The pharmaceutical industry is undergoing a period of rapid change. Merger and acquisition activity is high, regulations are becoming more stringent, and companies are forced to be evermore focused on cost. Regulation challenges were recently made more complex by the introduction of GDPR and uncertainty in Europe around Brexit.